All News

My initial reaction was fear: Fear of the unknown possibilities of what could happen as a result of this most dreaded diagnosis.

The EVEREST-2 study has reported the first complete response to CAR-T cell therapy in a patient with non-small cell lung cancer.

I reflect on caregiving, loss and gratitude, honoring the people who supported me through my sister’s cancer and my first Thanksgiving without her.

CURE spoke with Dr. Natalie S. Berger for the latest episode of the "Cancer Horizons" podcast.

Early-phase studies showed INCA033989 led to spleen reduction, symptom improvement and anemia responses in patients with calreticulin-mutated myelofibrosis.

Rusfertide keeps hematocrit under 45% and prevents phlebotomy for most patients with polycythemia vera through 52 weeks of treatment.

Updated VIKTORIA-1 data show gedatolisib plus Faslodex, with or without Ibrance, improves progression-free survival in PIK3CA wild-type advanced breast cancer.

Cancer survivorship invites deeper questions about what we allow into our bodies, our homes, and the lives of those we love most.

CURE spoke with an expert about smoking-related stigmas often faced by patients with lung cancer.

Dr. Roshani Patel answers questions from patients with breast cancer on Keytruda-induced colitis, sugar intake during chemo, and how to stay active.

Joe McDonough sat down for an interview with CURE to share his family’s story and the inspiration behind the B+ Foundation.

Mayra Andujar-Delgado shares how Dr. Faseeh Khaja’s compassionate care and unique bedside manner earned him recognition at the 2025 Blood Cancer Heroes.

Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.

Cancer survivor and author Bill Potts was recently honored as a Blood Cancer Hero.

Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER-positive, HER2-negative breast cancer.

CURE spoke with an expert about why a support system is crucial for patients with lung cancer.

BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, HER2-negative breast cancer is safe.

Learn how diet and exercise impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs.

CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.

All I can say is thank you Healthwell Foundation for giving our brother life, and for giving our whole family unit life. Because of you, we can keep on keeping on.

Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.

As kidney cancer survival improves, more patients report cognitive changes affecting memory, fatigue, and overall mental clarity

Christmas is my favorite time of year. Since my child was diagnosed with cancer, however, the only gift I want is one more Christmas with her being here.

Trodelvy elicited fewer side effects that led to dose reduction compared with chemotherapy in previously untreated triple-negative breast cancer.

Jace Yawnick explained why a support system is essential for patients with cancer.

I have been diagnosed with breast cancer for the third time, and I find it interesting how the places where I seek support have changed over time.

Clinical trials give patients with metastatic breast cancer access to new treatments, all while being closely monitored and moving the landscape forward.

Trodelvy led to fewer side effects that required dose reductions or stopping treatment vs chemo among previously untreated triple-negative breast cancer.